Seroatlas · Human Serome Atlas

CA8

Carbonic anhydrase-related protein

Also known as: CAH8_HUMAN, CALS, CARP

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P35219
Gene
CA8
Ensembl
ENSG00000178538
Chromosome
8
Canonical length
290 aa
Protein class
Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins

OverviewNCBI Gene

The protein encoded by this gene was initially named CA-related protein because of sequence similarity to other known carbonic anhydrase genes. However, the gene product lacks carbonic anhydrase activity (i.e., the reversible hydration of carbon dioxide). The gene product continues to carry a carbonic anhydrase designation based on clear sequence identity to other members of the carbonic anhydrase gene family. The absence of CA8 gene transcription in the cerebellum of the lurcher mutant in mice with a neurologic defect suggests an important role for this acatalytic form. Mutations in this gene are associated with cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CMARQ3). Polymorphisms in this gene are associated with osteoporosis, and overexpression of this gene in osteosarcoma cells suggests an oncogenic role. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]

Canonical amino-acid sequenceUniProt

290 residues, UniProt reviewed canonical sequence.

>P35219|CA8
     1  MADLSFIEDT VAFPEKEEDE EEEEEGVEWG YEEGVEWGLV FPDANGEYQS PINLNSREAR
    61  YDPSLLDVRL SPNYVVCRDC EVTNDGHTIQ VILKSKSVLS GGPLPQGHEF ELYEVRFHWG
   121  RENQRGSEHT VNFKAFPMEL HLIHWNSTLF GSIDEAVGKP HGIAIIALFV QIGKEHVGLK
   181  AVTEILQDIQ YKGKSKTIPC FNPNTLLPDP LLRDYWVYEG SLTIPPCSEG VTWILFRYPL
   241  TISQLQIEEF RRLRTHVKGA ELVEGCDGIL GDNFRPTQPL SDRVIRAAFQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CA8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.29
Highest tissue expression
38 nTPM

Expression across tissuesHPA

Tissue

  • parathyroid gland: 38 nTPM
  • cerebellum: 14 nTPM
  • epididymis: 9.6 nTPM
  • amygdala: 5.8 nTPM
  • basal ganglia: 5.8 nTPM
  • placenta: 5.8 nTPM

Single-cell type

  • renal collecting duct intercalated cells: 840 nCPM
  • sertoli cells: 501 nCPM
  • corticotrophs: 432 nCPM
  • epididymal clear cells: 280 nCPM
  • pituitary stem cells: 239 nCPM
  • endometrial secretory cells: 224 nCPM

Immune cell

  • basophil: 76 nTPM
  • plasmacytoid DC: 3.1 nTPM
  • eosinophil: 0.5 nTPM
  • memory B-cell: 0.2 nTPM
  • NK-cell: 0.1 nTPM
  • total PBMC: 0.1 nTPM

Brain region

  • cerebellum: 36 nTPM
  • basal ganglia: 9.3 nTPM
  • hypothalamus: 8.4 nTPM
  • amygdala: 8 nTPM
  • cerebral cortex: 8 nTPM
  • pons: 7.7 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CA8.

Disease | AllUniProt

Conditions CA8 is implicated in, by any mechanism.

Disease | GeneticClinVar

10 pathogenic / likely-pathogenic of 99 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.67
gnomAD pLI
0.01
gnomAD missense Z
1.24
DepMap mean gene effect
-0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CA8 as an antibody target. Whether an autoantibody or antibody against CA8 could matter depends on whether native CA8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CA8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CA8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CA8. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...